Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03563404 · ClinicalTrials.gov registry record
Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 20
- Enrollment target
NCT03563404: Completed study, sponsored by Medical University of South Carolina.
NCT03563404 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03563404 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
By showing that increased levels of acidotic metabolites and electrolytes in the systemic blood of patients who do not receive portal blood flush prior to reperfusion compared to patients who do receive portal blood flush, and that these increased levels correlate with cardiac depression as seen on TEE, the investigators hope to find a superior technique for liver reperfusion.
Primary Outcome
The primary objective of this study is to determine whether or not a portal blood flush is useful for maintaining hemodynamic stability in the peri-reperfusion stage of Orthotopic Liver Transplantation as evidence by TEE.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-06-29 |
| Est. Completion | 2016-06-29 |
What the finished NCT03563404 record still lists
NCT03563404 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03563404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03563404 about?
NCT03563404 is a clinical study titled "Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation". By showing that increased levels of acidotic metabolites and electrolytes in the systemic blood of patients who do not receive portal blood flush prior to reperfusion compared to patients who do receive portal blood flush, and that these increased levels correlate with cardiac depression as seen on ...
What is the current status of trial NCT03563404?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2015-06-29. Estimated completion is 2016-06-29.
Who is sponsoring clinical trial NCT03563404?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI